Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
作者： Debangshu Samanta , Daniele M. Gilkes , Pallavi Chaturvedi , Lisha Xiang , Gregg L. Semenza
关键词:
摘要: … HIF-1 has been implicated in resistance to chemotherapy (16, 17) and in hypoxic colon … of multidrug resistance 1 (MDR1) (18), which mediates efflux of chemotherapy from cancer cells …
harvard.edu
elsevier.com
researchgate.net 
sci-hub.se 参考文章(55)
Hege G. Russnes, Nicholas Navin, James Hicks, Anne-Lise Borresen-Dale, Insight into the heterogeneity of breast cancer through next-generation sequencing Journal of Clinical Investigation. ,vol. 121, pp. 3810- 3818 ,(2011) , 10.1172/JCI57088
Sreenivasulu Chintala, Károly Tόth, Shousong Cao, Farukh A. Durrani, Mary M. Vaughan, Randy L. Jensen, Youcef M. Rustum, Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α Cancer Chemotherapy and Pharmacology. ,vol. 66, pp. 899- 911 ,(2010) , 10.1007/S00280-009-1238-8
Nadine Rohwer, Thorsten Cramer, Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resistance Updates. ,vol. 14, pp. 191- 201 ,(2011) , 10.1016/J.DRUP.2011.03.001
Carmen Chak-Lui Wong, Huafeng Zhang, Daniele M. Gilkes, Jasper Chen, Hong Wei, Pallavi Chaturvedi, Maimon E. Hubbi, Gregg L. Semenza, Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis. Journal of Molecular Medicine. ,vol. 90, pp. 803- 815 ,(2012) , 10.1007/S00109-011-0855-Y
Annika Unruh, Anke Ressel, Hamid G Mohamed, Randall S Johnson, Roger Nadrowitz, Eckart Richter, Dörthe M Katschinski, Roland H Wenger, The hypoxia-inducible factor-1α is a negative factor for tumor therapy Oncogene. ,vol. 22, pp. 3213- 3220 ,(2003) , 10.1038/SJ.ONC.1206385
Gregg L. Semenza, HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations Journal of Clinical Investigation. ,vol. 123, pp. 3664- 3671 ,(2013) , 10.1172/JCI67230
Markus Ringnér, Erik Fredlund, Jari Häkkinen, Åke Borg, Johan Staaf, GOBO: Gene Expression-Based Outcome for Breast Cancer Online PLoS ONE. ,vol. 6, pp. e17911- 11 ,(2011) , 10.1371/JOURNAL.PONE.0017911
Piotr Przanowski, Michal Dabrowski, Aleksandra Ellert-Miklaszewska, Michal Kloss, Jakub Mieczkowski, Beata Kaza, Anna Ronowicz, Feng Hu, Arkadiusz Piotrowski, Helmut Kettenmann, Jan Komorowski, Bozena Kaminska, The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia. Journal of Molecular Medicine. ,vol. 92, pp. 239- 254 ,(2014) , 10.1007/S00109-013-1090-5
Christophe Ginestier, Suling Liu, Mark E. Diebel, Hasan Korkaya, Ming Luo, Marty Brown, Julien Wicinski, Olivier Cabaud, Emmanuelle Charafe-Jauffret, Daniel Birnbaum, Jun-Lin Guan, Gabriela Dontu, Max S. Wicha, CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts Journal of Clinical Investigation. ,vol. 120, pp. 485- 497 ,(2010) , 10.1172/JCI39397
Lisha Xiang, Daniele M. Gilkes, Pallavi Chaturvedi, Weibo Luo, Hongxia Hu, Naoharu Takano, Houjie Liang, Gregg L. Semenza, Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer. Journal of Molecular Medicine. ,vol. 92, pp. 151- 164 ,(2014) , 10.1007/S00109-013-1102-5